Monash IVF Group Ltd
ASX:MVF
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.545
1.2426
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
MVF
stock under the Base Case scenario is
1.348
AUD.
Compared to the current market price of 0.735 AUD,
Monash IVF Group Ltd
is
Undervalued by 45%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Monash IVF Group Ltd.
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
|
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
|
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
|
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
|
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
|
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
|
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
|
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
|
| US |
|
Universal Health Services Inc
NYSE:UHS
|
|
| ID |
S
|
Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Regulatory shifts or reduced government support for fertility services could significantly lower patient volumes, pressuring Monash IVF Group’s revenue and margins in its core Australian market.
Increased competition from both established IVF providers and emerging low-cost clinics may erode Monash IVF’s market share, forcing price concessions and reducing profitability.
A growing reliance on specialized fertility medical professionals, coupled with industry-wide shortages, could escalate staffing expenses or impede expansion if key medical talent is difficult to retain.
Monash IVF’s longstanding brand reputation and strong clinical success rates empower it to attract a steady stream of patients and top fertility specialists, reinforcing its leadership position.
Shifting demographics, including delayed family planning and rising infertility rates, support continued growth in IVF demand, which Monash IVF Group can capture both domestically and in Southeast Asia.
The company’s investment in emerging reproductive technologies and genetic screening capabilities enhances treatment outcomes, potentially boosting margins by drawing higher-end clientele and strengthening patient loyalty.
Revenue & Expenses Breakdown
Monash IVF Group Ltd
Balance Sheet Decomposition
Monash IVF Group Ltd
| Current Assets | 41.7m |
| Cash & Short-Term Investments | 9.4m |
| Receivables | 23.3m |
| Other Current Assets | 9m |
| Non-Current Assets | 450.9m |
| Long-Term Investments | 1.3m |
| PP&E | 146m |
| Intangibles | 297.2m |
| Other Non-Current Assets | 6.3m |
| Current Liabilities | 61.4m |
| Accounts Payable | 20.5m |
| Accrued Liabilities | 14.6m |
| Other Current Liabilities | 26.3m |
| Non-Current Liabilities | 184.9m |
| Long-Term Debt | 170.3m |
| Other Non-Current Liabilities | 14.6m |
Free Cash Flow Analysis
Monash IVF Group Ltd
| AUD | |
| Free Cash Flow | AUD |
Earnings Waterfall
Monash IVF Group Ltd
|
Revenue
|
271.9m
AUD
|
|
Cost of Revenue
|
-29.5m
AUD
|
|
Gross Profit
|
242.5m
AUD
|
|
Operating Expenses
|
-198.3m
AUD
|
|
Operating Income
|
44.2m
AUD
|
|
Other Expenses
|
-19.2m
AUD
|
|
Net Income
|
25m
AUD
|
MVF Profitability Score
Profitability Due Diligence
Monash IVF Group Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Score
Monash IVF Group Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
MVF Solvency Score
Solvency Due Diligence
Monash IVF Group Ltd's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Score
Monash IVF Group Ltd's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MVF Price Targets Summary
Monash IVF Group Ltd
According to Wall Street analysts, the average 1-year price target for
MVF
is 0.821 AUD
with a low forecast of 0.657 AUD and a high forecast of 0.998 AUD.
Dividends
Current shareholder yield for
MVF is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MVF
stock under the Base Case scenario is
1.348
AUD.
Compared to the current market price of 0.735 AUD,
Monash IVF Group Ltd
is
Undervalued by 45%.